These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 21725080)
1. Radiation dose management in CT, SPECT/CT and PET/CT techniques. Mattsson S; Söderberg M Radiat Prot Dosimetry; 2011 Sep; 147(1-2):13-21. PubMed ID: 21725080 [TBL] [Abstract][Full Text] [Related]
2. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities. Zanzonico P; Dauer L; St Germain J Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690 [TBL] [Abstract][Full Text] [Related]
3. Radiation exposure of patients and personnel from a PET/CT procedure with 18F-FDG. Leide-Svegborn S Radiat Prot Dosimetry; 2010; 139(1-3):208-13. PubMed ID: 20167792 [TBL] [Abstract][Full Text] [Related]
4. Radiation safety with positron emission tomography and computed tomography. Devine CE; Mawlawi O Semin Ultrasound CT MR; 2010 Feb; 31(1):39-45. PubMed ID: 20102694 [TBL] [Abstract][Full Text] [Related]
5. Technological advances in hybrid imaging and impact on dose. Mattsson S; Andersson M; Söderberg M Radiat Prot Dosimetry; 2015 Jul; 165(1-4):410-5. PubMed ID: 25802466 [TBL] [Abstract][Full Text] [Related]
6. PET/CT and SPECT/CT dosimetry in children: the challenge to the pediatric imager. Gelfand MJ; Lemen LC Semin Nucl Med; 2007 Sep; 37(5):391-8. PubMed ID: 17707244 [TBL] [Abstract][Full Text] [Related]
7. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease. Horger M; Bares R Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146 [TBL] [Abstract][Full Text] [Related]
8. Occupational per-patient radiation dose from a conservative protocol for veterinary (18) F-fluorodeoxyglucose positron emission tomography. Martinez NE; Kraft SL; Gibbons DS; Arceneaux BK; Stewart JA; Mama KR; Johnson TE Vet Radiol Ultrasound; 2012; 53(5):591-7. PubMed ID: 22703227 [TBL] [Abstract][Full Text] [Related]
9. Dose reduction in pediatric hybrid and planar imaging. Gelfand MJ Q J Nucl Med Mol Imaging; 2010 Aug; 54(4):379-88. PubMed ID: 20823806 [TBL] [Abstract][Full Text] [Related]
10. The determination of patient dose from (18)F-FDG PET/CT examination. Khamwan K; Krisanachinda A; Pasawang P Radiat Prot Dosimetry; 2010 Sep; 141(1):50-5. PubMed ID: 20400773 [TBL] [Abstract][Full Text] [Related]
11. Personal radiation doses in PET/CT facility: measurements vs. calculations. Hippeläinen E; Nikkinen P; Ihalainen T; Uusi-Simola J; Savolainen S Radiat Prot Dosimetry; 2008; 132(1):57-63. PubMed ID: 18713782 [TBL] [Abstract][Full Text] [Related]
12. PET and PET-CT in radiation treatment planning for lung cancer. Aristei C; Falcinelli L; Palumbo B; Tarducci R Expert Rev Anticancer Ther; 2010 Apr; 10(4):571-84. PubMed ID: 20397922 [TBL] [Abstract][Full Text] [Related]
13. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656 [TBL] [Abstract][Full Text] [Related]
15. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736 [TBL] [Abstract][Full Text] [Related]
16. The radioprotection management of a PET department with a cyclotron and radiopharmacy laboratory, in accordance with Italian legislation. Russo AA; Ferrari P; Casale M; Delia R Radiat Prot Dosimetry; 2011 Sep; 147(1-2):240-6. PubMed ID: 22039292 [TBL] [Abstract][Full Text] [Related]
17. [Clinical use of digital retrospective image fusion of CT, MRI, FDG-PET and SPECT -- fields of indications and results]. Lemke AJ; Niehues SM; Amthauer H; Rohlfing T; Hosten N; Felix R Rofo; 2004 Dec; 176(12):1811-8. PubMed ID: 15573293 [TBL] [Abstract][Full Text] [Related]
18. PET and PET/CT in pediatric oncology. Jadvar H; Connolly LP; Fahey FH; Shulkin BL Semin Nucl Med; 2007 Sep; 37(5):316-31. PubMed ID: 17707239 [TBL] [Abstract][Full Text] [Related]
19. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer. Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572 [TBL] [Abstract][Full Text] [Related]
20. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]